Timing of cyclosporine administration for GvHD prophylaxis in haploidentical stem cell transplantation setting: Single center experience

Curr Res Transl Med. 2023 Apr-Jun;71(2):103387. doi: 10.1016/j.retram.2023.103387. Epub 2023 Mar 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cyclosporine* / therapeutic use
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Immunosuppressive Agents / therapeutic use

Substances

  • Cyclosporine
  • Immunosuppressive Agents